Guggenheim Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,422
| Closed | -$314K | – | 1721 |
|
|
2024
Q4 | $314K | Buy |
+25,422
| New | +$291K | ﹤0.01% | 1433 |
|
|
2022
Q3 | – | Sell |
-19,715
| Closed | -$301K | – | 2067 |
|
|
2022
Q2 | $301K | Buy |
19,715
+9,642
| +96% | +$143K | ﹤0.01% | 1776 |
|
|
2022
Q1 | $205K | Buy |
10,073
+74
| +0.7% | +$1.51K | ﹤0.01% | 2042 |
|
|
2021
Q4 | $292K | Buy |
+9,999
| New | +$286K | ﹤0.01% | 1884 |
|
|
2018
Q2 | – | Sell |
-12,038
| Closed | -$35K | – | 2645 |
|
|
2018
Q1 | $35K | Buy |
12,038
+1,336
| +12% | +$4.13K | ﹤0.01% | 2721 |
|
|
2017
Q4 | $42K | Sell |
10,702
-1,336
| -11% | -$5.72K | ﹤0.01% | 2638 |
|
|
2017
Q3 | $38K | Buy |
12,038
+1,283
| +12% | +$4.82K | ﹤0.01% | 2713 |
|
|
2017
Q2 | $46K | Hold |
10,755
| – | – | ﹤0.01% | 2740 |
|
|
2017
Q1 | $49K | Buy |
10,755
+2,092
| +24% | +$7.01K | ﹤0.01% | 2737 |
|
|
2016
Q4 | $19K | Hold |
8,663
| – | – | ﹤0.01% | 2852 |
|
|
2016
Q3 | $26K | Sell |
8,663
-79
| -0.9% | -$212 | ﹤0.01% | 2802 |
|
|
2016
Q2 | $22K | Sell |
8,742
-635
| -7% | -$1.77K | ﹤0.01% | 2804 |
|
|
2016
Q1 | $28K | Buy |
9,377
+513
| +6% | +$2.75K | ﹤0.01% | 2810 |
|
|
2015
Q4 | $72K | Buy |
8,864
+2,162
| +32% | +$17.5K | ﹤0.01% | 2869 |
|
|
2015
Q3 | $48K | Sell |
6,702
-423
| -6% | -$3.53K | ﹤0.01% | 2856 |
|
|
2015
Q2 | $66K | Buy |
7,125
+319
| +5% | +$3.07K | ﹤0.01% | 2938 |
|
|
2015
Q1 | $64K | Buy |
6,806
+472
| +7% | +$4.54K | ﹤0.01% | 2903 |
|
|
2014
Q4 | $62K | Buy |
6,334
+1,286
| +25% | +$13K | ﹤0.01% | 2896 |
|
|
2014
Q3 | $48K | Sell |
5,048
-7,120
| -59% | -$79.7K | ﹤0.01% | 2930 |
|
|
2014
Q2 | $160K | Sell |
12,168
-1,496
| -11% | -$18.9K | ﹤0.01% | 2938 |
|
|
2014
Q1 | $181K | Buy |
13,664
+2,968
| +28% | +$39.1K | ﹤0.01% | 2912 |
|
|
2013
Q4 | $104K | Buy |
10,696
+1,573
| +17% | +$14.8K | ﹤0.01% | 2978 |
|
|
2013
Q3 | $90K | Buy |
9,123
+1,210
| +15% | +$12K | ﹤0.01% | 2862 |
|
|
2013
Q2 | $71K | Buy |
+7,913
| New | +$82.9K | ﹤0.01% | 2865 |
|
Other funds holding CDMO
Guggenheim Capital's CDMO Position: Q1 2025 in Review
Guggenheim Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 25,422 shares — an estimated $314K sold.
Guggenheim Capital first reported a position in CDMO in Q2 2013 and held it in 24 quarters. The position peaked at $314K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Guggenheim Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Guggenheim Capital sold 25,422 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $314K.
- Guggenheim Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
- Guggenheim Capital's Avid Bioservices, Inc. Common Stock position peaked at $314K in Q4 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Guggenheim Capital's 13F filing for Q1 2025, filed 14 May 2025.